← SynDRA
OMPENACLID
SynDRA canonical compound SYN0001188 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CKM |
|---|
| Mechanism of action | creatine kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- 3-guanidino-propionic acid
- Amidino beta-alanine
- Beta-guanidinopropionic acid
- N-carbamimidoyl-.beta.-alanine
- Oristar gpa
- RGX-202
- PNU-10483
- RGX202
- beta-guanidinopropionic acid
- beta-GPA
- Beta-Guanidinopropionic acid
- guanidinopropionic-acid
- 3-carbamimidamidopropanoic acid
- amidino beta-alanine
- N-(Aminoiminomethyl)-beta-alanine
- ORISTAR GPA
- UL1984YRKA
- 3-((diaminomethylidene)amino)propanoic acid
- 3-[(diaminomethylidene)amino]propanoic acid
- beta-guanidine propionic acid
- RefChem:782874
- SLC6A8 Inhibitor RGX-202
- DTXCID00111286
- RGX-202-01
- 3-Guanidinopropionic acid
- 3-guanidinopropanoic acid
- 3-Guanidinopropanoate
- 3-(diaminomethylideneamino)propanoic acid
- MFCD00045939
- b-Alanine, N-(aminoiminomethyl)-
- Beta-Guanadinopropionate
- 3-guanidinopropanoicacid
- 3-Guanidino-propionic acid
- A1D9S
- N-(Aminomethyl)-beta-alanine
- EINECS 206-530-0
- |A-Guanidinopropionic acid
- UNII-UL1984YRKA
- ompenaclid [INN]
Look up OMPENACLID in the interactive SynDRA portal →